No Data
No Data
Earnings Preview: PRVA to Report Financial Results Pre-market on February 27
Stifel Maintains Privia Health(PRVA.US) With Buy Rating, Maintains Target Price $26
Express News | JMP Securities Maintains Market Outperform on Privia Health Gr, Maintains $26 Price Target
Are Investors Undervaluing Privia Health Group, Inc. (NASDAQ:PRVA) By 49%?
Privia Health to Report Fourth Quarter 2024 Results on Thursday, February 27
Express News | Privia Health Group Inc : Jefferies Raises Target Price to $27 From $26